World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
105
Citations
38800
World Ranking
6796
National Ranking
3588

Richard J. Jones publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Richard J. Jones sits on this spectrum.

101–120 publications: 2 scientists 121–140 publications: 21 scientists 141–160 publications: 47 scientists 161–180 publications: 112 scientists 181–200 publications: 171 scientists 201–220 publications: 267 scientists 221–240 publications: 344 scientists 241–260 publications: 413 scientists 261–280 publications: 548 scientists 281–300 publications: 558 scientists 301–320 publications: 629 scientists 321–340 publications: 686 scientists 341–360 publications: 668 scientists 361–380 publications: 648 scientists 381–400 publications: 628 scientists 401–420 publications: 692 scientists 421–440 publications: 601 scientists 441–460 publications: 568 scientists 461–480 publications: 575 scientists 481–500 publications: 556 scientists 501–520 publications: 452 scientists 521–540 publications: 443 scientists 541–560 publications: 425 scientists 561–580 publications: 388 scientists 581–600 publications: 390 scientists 601–620 publications: 295 scientists 621–640 publications: 296 scientists 641–660 publications: 294 scientists 661–680 publications: 229 scientists 681–700 publications: 259 scientists 701–720 publications: 228 scientists 721–740 publications: 184 scientists 741–760 publications: 172 scientists 761–780 publications: 171 scientists 781–800 publications: 162 scientists 801–820 publications: 153 scientists 821–840 publications: 139 scientists 841–860 publications: 128 scientists 861–880 publications: 120 scientists 881–900 publications: 101 scientists 901–920 publications: 109 scientists 921–940 publications: 82 scientists 941–960 publications: 102 scientists 961–980 publications: 64 scientists 981–1,000 publications: 70 scientists 1,001–1,020 publications: 55 scientists 1,021–1,040 publications: 55 scientists 1,041–1,060 publications: 39 scientists 1,061–1,080 publications: 59 scientists 1,081–1,100 publications: 36 scientists 1,101–1,120 publications: 40 scientists 1,121–1,140 publications: 34 scientists 1,141–1,160 publications: 35 scientists 1,161–1,180 publications: 25 scientists 1,181–1,200 publications: 31 scientists 1,201–1,220 publications: 20 scientists 1,221–1,240 publications: 25 scientists 1,241–1,260 publications: 25 scientists 1,261–1,280 publications: 20 scientists 1,281–1,300 publications: 24 scientists 1,301–1,320 publications: 22 scientists 1,321–1,340 publications: 14 scientists 1,341–1,360 publications: 24 scientists 1,361–1,380 publications: 22 scientists 1,381–1,400 publications: 11 scientists 1,401–1,420 publications: 14 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 11 scientists 1,461–1,480 publications: 9 scientists 1,481–1,500 publications: 16 scientists 1,501–1,520 publications: 9 scientists 1,521–1,540 publications: 13 scientists 1,541–1,560 publications: 9 scientists 1,561–1,580 publications: 5 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 9 scientists 1,621–1,640 publications: 9 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 3 scientists 1,681–1,700 publications: 1 scientists 1,701–1,720 publications: 7 scientists 1,721–1,740 publications: 5 scientists 1,741 publications: 1 scientists 1,742+ publications: 100 scientists
101 publications 1,742+

This scientist: 569 publications — 68th percentile

68% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,742 publications or more.

Richard J. Jones D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Richard J. Jones sits on this spectrum.

70–71 D-Index: 175 scientists 72–73 D-Index: 285 scientists 74–75 D-Index: 451 scientists 76–77 D-Index: 536 scientists 78–79 D-Index: 636 scientists 80–81 D-Index: 728 scientists 82–83 D-Index: 764 scientists 84–85 D-Index: 759 scientists 86–87 D-Index: 716 scientists 88–89 D-Index: 740 scientists 90–91 D-Index: 665 scientists 92–93 D-Index: 635 scientists 94–95 D-Index: 609 scientists 96–97 D-Index: 597 scientists 98–99 D-Index: 497 scientists 100–101 D-Index: 450 scientists 102–103 D-Index: 491 scientists 104–105 D-Index: 380 scientists 106–107 D-Index: 400 scientists 108–109 D-Index: 347 scientists 110–111 D-Index: 325 scientists 112–113 D-Index: 295 scientists 114–115 D-Index: 290 scientists 116–117 D-Index: 225 scientists 118–119 D-Index: 223 scientists 120–121 D-Index: 212 scientists 122–123 D-Index: 189 scientists 124–125 D-Index: 199 scientists 126–127 D-Index: 195 scientists 128–129 D-Index: 175 scientists 130–131 D-Index: 132 scientists 132–133 D-Index: 137 scientists 134–135 D-Index: 119 scientists 136–137 D-Index: 116 scientists 138–139 D-Index: 95 scientists 140–141 D-Index: 102 scientists 142–143 D-Index: 82 scientists 144–145 D-Index: 83 scientists 146–147 D-Index: 75 scientists 148–149 D-Index: 51 scientists 150–151 D-Index: 59 scientists 152–153 D-Index: 55 scientists 154–155 D-Index: 68 scientists 156–157 D-Index: 48 scientists 158–159 D-Index: 56 scientists 160–161 D-Index: 49 scientists 162–163 D-Index: 42 scientists 164–165 D-Index: 43 scientists 166–167 D-Index: 24 scientists 168–169 D-Index: 27 scientists 170–171 D-Index: 26 scientists 172–173 D-Index: 31 scientists 174–175 D-Index: 30 scientists 176–177 D-Index: 23 scientists 178–179 D-Index: 13 scientists 180–181 D-Index: 16 scientists 182–183 D-Index: 21 scientists 184–185 D-Index: 16 scientists 186–187 D-Index: 15 scientists 188–189 D-Index: 14 scientists 190–191 D-Index: 11 scientists 192–193 D-Index: 17 scientists 194–195 D-Index: 8 scientists 196–197 D-Index: 8 scientists 198–199 D-Index: 10 scientists 200–201 D-Index: 12 scientists 202–203 D-Index: 11 scientists 204–205 D-Index: 6 scientists 206–207 D-Index: 6 scientists 208–209 D-Index: 4 scientists 210 D-Index: 2 scientists 211+ D-Index: 100 scientists
70 D-Index 211+

This scientist: 105 D-Index — 67th percentile

67% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 211 D-Index or more.

Overview

Richard J. Jones is affiliated with Johns Hopkins University in the United States. Their research primarily centers on medicine, with a significant focus on hematology, genetics, oncology, public health, environmental and occupational health, and immunology.

Their work addresses key topics including hematopoietic stem cell transplantation, acute myeloid leukemia research, acute lymphoblastic leukemia research, myeloproliferative neoplasms: diagnosis and treatment, chronic myeloid leukemia treatments, polyomavirus and related diseases, and renal transplantation outcomes and treatments.

Among the frequent venues where Richard J. Jones publishes are:

  • Blood
  • Transplantation and Cellular Therapy
  • Blood Advances
  • Journal of Clinical Oncology
  • Leukemia & lymphoma/Leukemia and lymphoma

Frequent coauthors include:

  • Amy E. DeZern
  • Javier Bolaños-Meade
  • Ravi Varadhan
  • Richard F. Ambinder
  • Mark J. Levis

Notable recent publications by Richard J. Jones include:

  • Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis (2023), New England Journal of Medicine
  • Double unrelated umbilical cord blood vs HLA-haploidentical bone marrow transplantation: the BMT CTN 1101 trial (2020), Blood
  • Haploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamide (2020), Blood Advances
  • Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of FLT3 (2024), Journal of Clinical Oncology
  • Relationship of donor age and relationship to outcomes of haploidentical transplantation with posttransplant cyclophosphamide (2021), Blood Advances

Best Publications

  • HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide

    Leo Luznik;Paul V. O'Donnell;Paul V. O'Donnell;Heather J. Symons;Allen R. Chen

  • Venoocclusive disease of the liver following bone marrow transplantation

    Richard J. Jones;Kamthorn S. K. Lee;William E. Beschorner;Victor G. Vogel

  • Characterization of clonogenic multiple myeloma cells

    William H Matsui;Carol Ann Huff;Qiuju Wang;Matthew T Malehorn

  • Cyclophosphamide and cancer: golden anniversary.

    Ashkan Emadi;Richard J. Jones;Robert A. Brodsky

  • Decreased erythropoietin response in patients with the anemia of cancer.

    Carole B. Miller;Richard J. Jones;Steven Piantadosi;Martin D. Abeloff

  • Inhibition of apoptosis during development of colorectal cancer.

    Atul Bedi;Pankaj J. Pasricha;Adil J. Akhtar;James P. Barber

  • Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia

    Atul Bedi;Barbara A. Zehnbauer;James P. Barber;Saul J. Sharkis

  • Clonogenic Multiple Myeloma Progenitors, Stem Cell Properties, and Drug Resistance

    William Matsui;Qiuju Wang;James P. Barber;Sarah Brennan

  • Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide

    P.V O'Donnell;L Luznik;R.J Jones;G.B Vogelsang

  • Separation of pluripotent haematopoietic stem cells from spleen colony-forming cells

    Richard J. Jones;John E. Wagner;Paul Celano;Milada S. Zicha

  • Microtubule changes and cytotoxicity in leukemic cell lines treated with taxol.

    Eric K. Rowinsky;Ross C. Donehower;Richard J. Jones;Robert W. Tucker

  • Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantation

    Louise B. Grochow;Richard J. Jones;Robert B. Brundrett;Hayden G. Braine

  • BCR-ABL-mediated inhibition of apoptosis with delay of G2/M transition after DNA damage: a mechanism of resistance to multiple anticancer agents

    Atul Bedi;James P. Barber;Gauri C. Bedi;Wafik S. El-Deiry

  • High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease.

    Leo Luznik;Javier Bolaños-Meade;Marianna Zahurak;Allen R. Chen

  • HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease.

    Javier Bolaños-Meade;Ephraim J. Fuchs;Leo Luznik;Sophie M. Lanzkron

  • Evidence of a graft-versus-lymphoma effect associated with allogeneic bone marrow transplantation.

    Richard J. Jones;Richard F. Ambinder;Steven Piantadosi;George W. Santos

  • Assessment of aldehyde dehydrogenase in viable cells

    R J Jones;J P Barber;M S Vala;M I Collector

  • Association of Foxp3 regulatory gene expression with graft-versus-host disease

    Yuji Miura;Christopher J. Thoburn;Emilie C. Bright;Michele L. Phelps

  • Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and β-thalassemia

    Robert Iannone;James F Casella;Ephraim J Fuchs;Allen R Chen

  • Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation.

    Atul Bedi;Carole B. Miller;Janet L. Hanson;Steven Goodman

Frequent Co-Authors

Ephraim J. Fuchs
Ephraim J. Fuchs Johns Hopkins University
Richard F. Ambinder
Richard F. Ambinder Johns Hopkins University
Leo Luznik
Leo Luznik Johns Hopkins University
B. Douglas Smith
B. Douglas Smith Johns Hopkins University
Marianna Zahurak
Marianna Zahurak Johns Hopkins University
Georgia Boyce Vogelsang
Georgia Boyce Vogelsang Johns Hopkins University
Mark J. Levis
Mark J. Levis Johns Hopkins University
James Barber
James Barber Imperial College London
Saul J. Sharkis
Saul J. Sharkis Johns Hopkins University School of Medicine
Constance A. Griffin
Constance A. Griffin Johns Hopkins University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine isn’t limited to becoming a doctor or surgeon. There are numerous related fields offering rewarding opportunities through accessible and flexible online education options. Many students are now considering roles like medical coding, nursing, and advanced practice nursing, which have become more attainable thanks to a variety of affordable online programs.

If you’re interested in healthcare administration, learning how much does it cost to become a medical coder can help you understand the financial investment required to gain these valuable skills. For registered nurses looking to advance their careers, bridging programs such as the cheapest rn to bsn online offer flexible pathways to a bachelor’s degree.

Those aiming for higher clinical positions may find the cheapest nurse practitioner programs appealing. For nurses interested in academia or research, an online phd in nursing can open doors to leadership roles and advanced scholarship in the field.

Exploring these related online degrees and career pathways ensures that aspiring healthcare professionals have diverse, affordable options to achieve their educational and professional goals in the USA.

Best Scientists Citing Richard J. Jones

Trending Scientists

Recently Published Articles